Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-28 @ 10:10 AM
Study NCT ID:
NCT05841420
Status:
RECRUITING
Last Update Posted:
2025-01-29
First Post:
2023-03-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer
Sponsor:
Morten Ladekarl
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-16
First Submit QC Date:
None
Study First Post Date:
2023-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-27
Last Update Post Date:
2025-01-29
Last Update Post Date Type:
ACTUAL